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The MT-2 cell line transformed by human T-cell leukemia virus type 1 (HTLV-1) contains one complete provirus and seven
defective proviruses. Four defective genomes have an identical structure (LTR-MA-dCA-pX-LTR) with an open reading frame
that spans from MA to pX, giving rise to a 3.4-kb (24S) RNA transcript encoding a chimeric Gag–pX protein, p28. MT-2 cells
release two distinct types of virions. The major “classic” type of particle has a buoyant density of 1.155–1.16 g/cm3 and
contains the standard HTLV-I structural proteins and reverse transcriptase (RT). In addition, about 5% of particles are “light,”
approximately 1.12 g/cm3, and contain p28, RT activity, and the 3.4-kb RNA transcript. RT-PCR and in vitro translation indicate
that some of the classic HTLV-1 particles package 3.4-kb RNA as well as full-length 8.5-kb RNA. In addition to matrix features,
the p28 protein has a motif resembling a zinc finger at the C-terminal, pX0 region, which may play a role in the assembly of
the defective light virions. © 1999 Academic Press
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cINTRODUCTION
Human T-cell leukemia virus type 1 (HTLV-1, Poiesz et
l., 1980) is the causative agent of adult T-cell lympho-
a–leukemia (ATL) and tropical spastic paraparesis,
lso known as HTLV-1-associated myelopathy (TSP/
AM) (Hinuma et al., 1981; Yoshida et al., 1982; Gessain
t al., 1985; Osame et al., 1986). Although HTLV-1 was the
irst human retrovirus to be characterized, its study has
een somewhat hampered by poor infectivity as cell-free
irus (Clapham et al., 1983). Cell lines derived from pe-
ipheral blood mononuclear cells (PBMCs) of ATL and
SP/HAM patients are frequently used for the analysis of
irus-induced pathogenesis, viral replication, and mor-
hogenesis. Genomes of HTLV-1 from ATL and several
SP/HAM patients were completely sequenced (Seiki et
l., 1983; Malik et al., 1988; Evangelista et al., 1990). In
ddition to complete proviruses, ATL- and TSP/HAM-
erived cell lines and tumor samples frequently contain
efective proviruses that can be expressed (Hiromatsu
nd Yoshikura, 1986; Malik et al., 1988; Korber et al., 1991;
hat et al., 1993). The role of these proviruses in patho-
enesis is still obscure.
The MT-2 cell line is derived from bone marrow CD41
-lymphocytes of a healthy donor after cocultivation with
eukemia cells of an ATL patient (Miyoshi et al., 1981a, b).
t is widely used as a relatively efficient HTLV-1 produc-
ng cell line (Nagy et al., 1983) and for HIV typing of
yncytium inducing (SI) strains (Tersmette et al., 1988).
ne complete provirus and seven defective proviruses
1 To whom correspondence and reprint requests should be ad-
Mressed. Fax: 44 (171) 352 3044. E-mail: robinw@icr.ac.uk.
279ere detected in MT-2 cells (Kobayashi et al., 1984). Four
f the defective proviruses are identical, with large inter-
al deletions while both long terminal repeats (LTRs), the
9 portion of gag, and the pX region are intact. These
efective proviruses give rise to a 3.4-kb (24S) transcript
ith an open reading frame that spans from the first ATG
f gag to the 59 region of the pX region and codes for a
90-amino-acid-long chimeric protein. This myristylated
rotein, p28, is composed of p19 (MA), truncated p24
CA), and a short pX region (Kobayashi et al., 1984;
chneider et al., 1984; Iino et al., 1986). P28 was shown
o be a protein kinase, but phosphorylated in a different
ay from p19 (Iino et al., 1986). The 3.4-kb mRNA tran-
cript is readily detected in MT-2 cells and directs p28
ynthesis (Kobayashi and Hatanaka, 1986). Since the 59
TR and 59 gag sequences are intact in the “p28” provi-
us, the packaging sequence (c) is present in the 3.4-kb
NA transcript that was found in association with a
rude unfractionated virus pellet (Kobayashi and Ha-
anaka, 1986). However, it was not clear whether this
NA was virus associated or represented a cell contam-
nant. It was recently reported that the 3.4-kb transcript
an be reversed transcribed when MT-2 cells are cocul-
ivated with HUT-78 cells (Benovic et al., 1998).
Little is known about HTLV-1 defective genome deliv-
ry or replication or the possible impact of defective
iruses in disease progress. We have used the MT-2 cell
ine as an experimental model of defective HTLV-1 pro-
iruses, for expression, packaging, and translation. We
eport here on the nature and distribution of p28 and
orresponding 3.4-kb RNA in particles released from
T-2 cells.
0042-6822/99 $30.00
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280 MOROZOV AND WEISSRESULTS
To analyze the distribution and composition of HTLV-I
irions, the virus particles were pelleted from MT-2 cell
upernatant and were fractionated on sucrose gradients.
igure 1 demonstrates the distribution of reverse tran-
FIG. 1. Reverse transcriptase activity associated with virus particles
eparated on sucrose density gradient. 1, reaction with exogenous
oly(rA)–oligo(dT); 2, reaction without exogenous template. Density of
ach fraction: 1, 1.10 g/cm3; 2, 1.11 g/cm3; 3, 1.12 g/cm3; 4, 1.125 g/cm3; 5,
.135 g/cm3; 6, 1.145 g/cm3; 7, 1.155 g/cm3; 8, 1.16 g/cm3; 9, 1.165 g/cm3;
0, 1.17 g/cm3; 11, 1.175 g/cm3.
FIG. 2. Comparative analysis of HTLV-1 proteins associated with vir
ntibodies. Lanes 1, 1.11 g/cm3; 2, 1.12 g/cm3; 3, 1.125 g/cm3; 4, 1.135 g/
0, 1.175 g/cm3. (A) Anti-p19, p28, (B) anti-p19, p28, Pr53gag, (C) anti-p2
Amersham, UK, not shown) were used for gel calibration.criptase (RT) activity across a 30–50% sucrose gradient.
s expected, the highest level of RT activity is observed
n fractions of density 1.155–1.16 g/cm3. However, a minor
eak was detected in fractions of density 1.12–1.13 g/cm3.
he amount of [3H]thymidine incorporation in fractions
.12–1.13 g/cm3 was approximately 5% of that observed in
he principal virus-containing fractions. As a control the
ame reaction mixture was used without exogenous
emplate, yielding a small peak at 1.155 g/cm3.
We examined the protein composition of virions in
ifferent fractions. Figure 2 shows Western blots of virus-
pecific proteins in association with fractions of density
.11 to 1.175 g/cm3 (tracks 1–10). The two monoclonal
ntibodies recognizing both p19 (MA) and p28 (Figs. 2A
nd 2B) revealed in fraction 2 (1.12 g/cm3) and fraction 3
1.125 g/cm3) mostly p28 with less p19 and Pr 53gag.
owever, the level of p28 was lower in fractions from
.135 to 1.155 g/cm3 (lanes 4, 5, and 6). In the denser
ractions (lane 7, 1.165 g/cm3; and lane 8, 1.165 g/cm3) the
oncentration of p28 increased, but was lower than that
f p19. To estimate relative amounts of p19 and p28 in the
wo peak virus-containing fractions, serial twofold dilu-
ions of the virus preparation from fractions 3 and 7 were
arried out. The p19 concentration in fraction 7 was
early eight times higher than that of p28, whereas the
mount of p28 in fraction 3 was nearly four times higher
icles of different densities detected by Western blot with monoclonal
1.145 g/cm3; 6, 1.155 g/cm3; 7, 1.16 g/cm3; 8, 1.165 g/cm3; 9, 1.17 g/cm3;
nti-p21 E. Antibodies were used at a 1:500 dilution. Rainbow markersus part
cm3; 5,
4, (D) a
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281DEFECTIVE HTLV-I PARTICLEShan that of p19, indicating that p28 is a major virus
rotein in the “light” fraction. Using the Mab against p24
CA) (Fig. 2C), p24 protein was detected mostly in frac-
ions 7 and 8 as expected, with traces in fractions 2 and
. The low concentration of p24 in fractions 2 and 3 was
onfirmed with a TSP/HAM patient serum (not shown).
nalysis of incorporation of env gene products was car-
ied out by Western blot analysis with an anti-p21E Mab
Fig. 2D). Traces of gp21 (TM) were revealed in fractions
and 3 as well as a 32-kDa protein of unknown origin.
his protein was also detected in fractions 7 and 8, but
n lower amounts than that of gp21 (TM). Since this
rotein was not previously described among env-coded
roteins, it may be of cellular origin. Traces of the SU Env
rotein, gp46, were also evident in fractions 2 and 3 with
he TSP/HAM antiserum (not shown).
Thus, both RT and Western blot data indicated that two
ypes of particle are present in the supernatant of MT-2
ells. The minor group of light particles with a density of
early 1.12 g/cm3 contained predominantly p28 and small
mounts of p19 (MA) and Pr53gag. The major group of
articles is composed of “classical” HTLV-1 (density
.155–1.17 g/cm3) with a standard protein pattern. Tech-
ically it is not easy to obtain complete separation of
hese two groups on sucrose density gradients and as a
onsequence it is difficult to make a precise relative
stimation of minor group amount in total viral popula-
ion. Based on RT activity we estimate that the minor
roup of particles represents nearly 5% of the total ex-
racellular virus, although RT may not be efficiently pack-
ged in these particles.
Analysis of the distribution of 3.4-kb defective viral
NA was carried out using RT-PCR with a forward primer
n the p19gag region and a backward primer in the pX
egion of the HTLV-I genome. Figure 3A demonstrates
he presence of 3.4-kb RNA in all fractions from 2 to 10,
ndicative that p28 RNA is present in both virus-contain-
ng fractions. To compare the 3.4-kb RNA load in frac-
ions 3 and 7 we performed serial dilution of RNA before
T-PCR (Fig. 3B) followed by agarose gel electrophore-
is. The 3.4-kb RNA level was equivalent in most frac-
ions or possibly slightly higher in fraction 3. Using RT-
CR primers within gag (portions 1187–1210 and 1886–
909) to identify sequences specific to the full-length
.5-kb RNA genome, positive results were seen in the
ajor peak only (Fig. 3C). Thus, bearing in mind that the
ight population is only 5% of the total virion population,
e concluded that it contained only 3.4-kb RNA.
To confirm that the RT-PCR amplimers were identical
o the p28 provirus, the fragments from fractions 3 and 7
f Fig. 3A were cloned and sequenced. Sequence anal-
sis of the 543-bp fragment of nucleotides 813–1356
evealed a chimeric gag–pX structure identical to that of
ucleotides 813–8156 in the p28 provirus (Kobayashi et
l., 1984), except for one point mutation, C for T, at
osition 1345. oTo verify that classical HTLV-1 (density 1.155–1.16
/cm3) could contain a mixed population of both full-size
.5-kb RNA and 3.4-kb RNA, while light particles contain
ostly 3.4-kb RNA, we performed in vitro translation in
abbit reticulocytes (Fig. 4). To our surprise more p28
han Pr53gag was expressed from RNA extracted from
raction 7 (lane 4), whereas only p28 was expressed from
NA of fraction 3 (lane 2). These results indicate that
.4-kb RNA is present in both classical and light HTLV-1
articles and that this RNA can be efficiently translated.
On comparing the sequences of a p28 provirus and
he full-length HTLV-1 provirus in MT-2 cells, we noted 10
ucleotide changes in the p28 open reading frame, yet
FIG. 3. (A) RT-PCR analysis of 3.4-kb RNA distribution along the
ucrose gradient. Lane—, negative control; lane M, markers; lane 1,
NA from MT-2 cells (positive control). (A) Lanes 1, 1.10 g/cm3; 2, 1.11
/cm3; 3, 1.12 g/cm3; 4, 1.125 g/cm3; 5, 1.135 g/cm3; 6, 1.145 g/cm3; 7, 1.155
/cm3; 8, 1.16 g/cm3; 9, 1.165 g/cm3; 10, 1.17 g/cm3. (B) Serial 10-fold
ilutions of fractions 3 (F3) and 7 (F7) followed by RT-PCR. (C) Absence
f full-size genomic RNA in light particles, by RT-PCR of a 723-bp
ragment of HTLV-I gag in the CA coding region (nucleotides 1187–
909). Lane 1, RNA from light fraction 3; lane 2, RNA from fraction 7; lane
, RNA from MT-2 cells (positive control); lane 4, water; lane 5, RNA
rom HTLV-I negative CEM cells.nly 3 nucleotides are different between the MT-2 p28
p
H
(
t
c
t
a
t
t
H
s
v
a
t
d
w
n
i
v
b
a
p
e
t
c
d
B
p
s
p
(
T
l
p
p
i
p
c
H
p
g
p
c
r
a
w
b
p
H
m
d
n
l
s
f
t
a
o
n
(
N
(
N
R
i
p
p
s
H
p
N
t
t
t
a
f
t
l
(
p
v
l
p
R
c
t
H
i
a
f
s
282 MOROZOV AND WEISSrovirus and the corresponding region of a complete
TLV-1 provirus from an unrelated TSP/HAM patient
Evangelista et al., 1990). It is therefore conceivable that
wo different proviruses were present in the leukemic
ells of the ATL patient that after cocultivation gave rise
o the MT-2 cell line.
We have examined the amino acid sequence of p28
nd detected a putative zinc-finger-like motif at its C-
erminus, representing the pX0 reading frame: nucleo-
ides 1330–1368. The sequence is His-Asn-Tyr-Cys-Asn-
is-Ile-Ala-Ser-Ser-Leu-Pro-Cys. The significance of this
equence is speculative, but it might have a function in
irion assembly as we have shown here that both p28
nd 3.4-kb RNA are copackaged in the light particles.
It is difficult to obtain titratable cell-free HTLV-1 infec-
ion in vitro (Clapham et al., 1983). However, in order to
etect possible infection of cells with defective HTLV-1
e exposed primary human PBMCs to cell-free super-
atant from MT-2 cells. PBMCs were cultivated for 2 days
n virus-containing medium and for another 10 days in
irus-free medium. Cell lysates and DNA were examined
y Western blot and PCR, respectively, 16 h, 24 h, 48 h,
nd 10 days postinfection. Neither p28 provirus nor p28
rotein expression was detectable and there was no
vidence of HTLV-I infection. However, it does not mean
hat infection could not take place in vivo, and in vitro
ocultivation evidence for reverse transcription of the
efective MT-2 3.4-kb RNA has recently been reported by
enovic et al. (1998).
DISCUSSION
We provide evidence of a mixed population of virus
articles released from MT-2 cells. Light particles (den-
ity approximately 1.12 g/cm3) are composed mostly of
28 protein, but also contain smaller amounts of p19
MA) and traces of Pr53gag, gp21 (TM), and gp46 (SU).
he 3.4-kb RNA encoding p28 is associated with these
FIG. 4. Analysis of coding capacities of the RNAs associated with
lassical and light HTLV-1 particles in a TNT in vitro transcription/
ranslation system. Translation products were precipitated with TSP/
AM patient serum. Lanes 1–3, RNA from fraction 3, light particles
mmunoprecipitated with TSP/HAM patient serum, monoclonal anti-p19
ntiserum, and normal human serum, respectively; Lane 4, RNA from
raction 7, classical particles; immunoprecipitated with the TSP/HAM
erum.ight particles, which constitute about 5% of the total virus sopulation by RT activity. Since the amount of p24 and
19 was low in the light fractions, it seems likely that p28
s able to substitute, at least in part, for Pr53gag during
article morphogenesis. The “heavy” or classical parti-
les (density nearly 1.16 g/cm3) contained the standard
TLV-I protein pattern with some p28 also present, com-
rising nearly 10% of p19. RT-PCR data on packaged
enome sequences indicate that at least some classical
articles are mixed and therefore might be heterozygous,
ontaining both full-length 8.5-kb RNA and 3.4-kb RNA. It
emains to be examined whether genotypically mixed
nd heterozygous particles are infectious and if so,
hether the reverse transcripts of 3.4-kb RNA reported
y Benovic et al. (1998) are derived from classical or light
articles.
Electron microscopic examination of MT-2 and other
TLV-I infected cells show two major types of virion
orphology: full-size 110-nm-diameter particles with
ense cores and smaller particles lacking a distinct
ucleoid (Miyoshi et al., 1981a; Timar et al., 1987). The
ight particles containing p28 and 3.4-kb RNA might pos-
ibly represent the latter type of morphology. It will there-
ore be interesting to see whether the two morphological
ypes can be separated by sucrose gradient fraction-
tion.
The assembly of retroviral RNA into virions depends
n an interaction of c sequences in the genome with the
ucleocapsid (NC) protein derived from Gag precursor
Berkowitz et al., 1996; Swanstrom and Wills, 1997); the
C of HIV-1 is actively involved in particle assembly
Ottmann et al., 1995; Zhang et al., 1998). The absence of
C sequences in p28 may explain the lack of genomic
NA in the light particles, but it does not explain the
ncorporation of the 3.4-kb, c-containing transcript. We
ostulate that the p28 chimeric MA–pX0 protein may
artially serve the function of NC. We have noted a
equence at the C-terminus of p28 containing Cys and
is sequences that may have properties of a zinc finger
rotein. Although this motif is not spaced precisely as in
C proteins, the Cys-His box might nonetheless permit
he encapsidation of the 3.4-kb transcript. The p28 pro-
ein does not, however, contain a sequence resembling
he I domain of NC, which is involved in Gag–Gag inter-
ction resulting in close packing of Gag precursors to
orm particles (Swanstrom and Wills, 1997). Mutations in
he I domain of other retroviruses yielded particles of
ower than normal buoyant density in sucrose gradients
Gonzalez et al., 1993) like those described here.
Thus the Cys-His box attached to the MA sequence of
28 may allow the assembly of 3.4-kb RNA into light
irions. In addition, it has been reported that in bovine
eukemia virus, a tax-rex virus related to HTLV-I, the MA
rotein may play a role in the selective binding of viral
NA (Katoh et al., 1991). MA also controls the conden-
ation and budding of virions at the cell membrane, via
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283DEFECTIVE HTLV-I PARTICLESts myristyl group and other sequences (Zhou et al., 1994;
wanstrom and Wills, 1997).
Here we have shown that a minor particle fraction has
ight virions incorporating mainly 3.4-kb RNA and the p28
rotein it encodes. The zinc finger-like motif at the C-
erminus of p28 may contribute to its incorporation and
nteraction with RNA, possibly substituting for the func-
ion of NC, while its myristylated MA-derived N-terminus
ay aid in the budding process. In general, it is likely that
n some cases defective retroviral transcripts with pack-
ging signals (c) can be copackaged with a full-size
enomic RNA inside the virion and thus be delivered to
he target cell, reverse transcribed, and integrated into
he host genome using the proteins of the helper virus.
his is the case for defective, oncogene-carrying retro-
irus. Recombination events between complete and de-
ective transcripts could take place, giving rise to new
iral variants. Other human retroviruses such as HIV also
enerate defective proviruses (Sanchez et al., 1997) and
e have detected defective HTLV-1 proviruses in vivo
unpublished observations). It will be interesting to de-
ermine whether similar types of defective, packageable
enomes with open reading frames are present in vivo in
TLV and HIV infection and might contribute to patho-
enesis.
MATERIALS AND METHODS
irion purification and reverse transcriptase activity
Virus particles were isolated from 700 ml of MT-2 cell
upernatant by differential centrifugation and pelleted
hrough a 20% sucrose cushion at 35,000 rpm for 90 min.
he virus pellet was resuspended in TN (0.01M Tris–HCl;
H 7.4, 0.1 M NaCl) buffer containing 0.5 mg aprotinin/ml
nd purified on a 20–60% or a 30–50% sucrose gradient
t 120,000 g for 6 h. After density estimation, fractions
ere diluted 1:4 with TN/aprotinin and pelleted at
10,000 g for 90 min. Pellets were diluted in 60 ml of
N/aprotinin and frozen at 270°C. One microliter from
ach fraction was used in a RT assay with poly(rA)–
ligo(dT) as exogenous template and Mg21 as divalent
ation, as described (Nagy et al., 1983). Centrifugation
hrough the conventional 20–60% sucrose gradient did
ot yield clear peaks. Using the same centrifugation
onditions we therefore prepared another, more “smooth”
0–50% sucrose gradient, which provided better separa-
ion of fractions between 1.10 and 1.20 g/cm3.
irion protein analysis
To analyze virus-specific proteins 10 ml from each
raction was separated by electrophoresis on a 4–20%
radient precast gel (Novex, San Diego, CA) followed by
ransfer of proteins on a 0.22-mm nitrocellulose mem-
rane (Schleicher & Schull BA83) and Western blot was
erformed with a set of monoclonal antibodies (obtained Crom Chemicon Inc., USA) that recognized (A) p19 (MA)
nd p28; (B) p19 (MA), p28, and Pr53gag.; (C) p24 (CA);
nd (D) p21E (TM).
irion RNA analysis and translation
To estimate the relative load of 3.4-kb RNA in each
raction of the gradient, RNA was isolated from virus
articles using RNAzol B reagent (Biotecx Laboratories
nc., USA). Analysis of virus-associated RNA was carried
ut by RT-PCR, using a set of primers corresponding to
he gag (positions 810–833; 59CAA ATC TTT TCC CGT
GC GCT AGC) and pX (positions 6684–6664 in ATK;
ositions 1356–1336 in the p28 provirus, 59 GGA GGC
AT GTA GTT GCA ATA) region. The reaction was per-
ormed using a Titan one-tube RT-PCR kit (Boehringer
annheim, Germany). The absence of proviral DNA in
he RNA samples was confirmed by direct PCR using the
ame pair of primers.
To obtain nucleotide sequences, the RT-PCR am-
limers were purified on low-melting-point agarose us-
ng a PCR purification kit (Promega, Madison, WI) and
loned in a pTLarge T vector (Promega). The nucleotide
equencing reaction was done with an ABI Prism Dye
ermination Cycle Sequencing Ready Reaction Kit (Per-
in–Elmer Corp., UK) containing an upstream plasmid
rimer and sequencing was performed using an ABI
77A automated sequencer.
In vitro translation of virion RNA was performed in
abbit reticulocytes using a TNT transcription/translation
ystem (Promega). The RNA pools isolated from fractions
and 3 were incubated for 90 min at 30°C in a reaction
ixture containing [14C]leucine. Synthesized proteins
ere examined by radioimmunoprecipitation, in which
5 ml of reaction mixture was mixed with 3 ml TSP/HAM
atient serum for 2 h at 4°C and protein A linked to
epharose 4B beads (Sigma, St Louis, MO) was added
or 16 h to precipitate immune complexes. The washed
recipitates were analyzed by polyacrylamide gel elec-
rophoresis, followed by fluorography.
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